Treating Blood Cancers

Ramy Sedhom, MD, FASCO, University of Pennsylvania, Plainsboro, NJ Recorded on August 13, 2026 Ramy Sedhom, MD, FASCO Associate Professor, Clinical Medicine, Division of Hematology/Oncology Director, Program in Geriatric Oncology & Supportive Care Innovation and the Center for Cancer and Aging at the Penn Center for Cancer Care Innovation University of Pennsylvania Plainsboro, NJ In this episode, Dr. Ramy Sedhom from the University of Pennsylvania explores the role of bereavement support in oncology care. He discusses how clinicians can support patients’ families after a loss, recognize when grief may require additional intervention, and incorporate meaningful bereavement practices into routine care. The conversation also examines the impact of patient loss on healthcare professionals and offers practical strategies to reduce clinician moral distress and burnout. Tune in today for this thoughtful conversation! Mentioned on this episode: The Journal of Palliative Medicine: Top Ten Tips on Bereavement Care Man’s Search for Meaning by Viktor E. Frankl It’s OK That You’re Not OK by Megan Devine Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN Recorded on June 23, 2026 Stephen Ansell, MD, PhD Division Chair, Hematology Mayo Clinic Rochester, MN Join Dr. Stephen Ansell from Mayo Clinic for an in-depth discussion on Waldenström macroglobulinemia, focusing on the latest advances in diagnosis, treatment, and management. This episode explores clinical features, the importance of molecular markers in guiding diagnosis and treatment decisions, and current indications for initiating therapy. The discussion also addresses the management of IgM-related complications, emerging therapeutic approaches, and future directions in care. Listen to this exciting and informative episode today! Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

Marina Kremyanskaya, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY Recorded on June 2, 2026 Marina Kremyanskaya, MD, PhD Associate Professor Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York, NY Join Dr. Marina Kremyanskaya from the Icahn School of Medicine at Mount Sinai in this expert discussion on mastocytosis, including an overview of the disease, key signs and symptoms, and current diagnostic criteria with a focus on relevant genetic mutations. She discusses recently approved therapies, emerging treatment approaches, and ongoing clinical trials that are shaping future treatment. The episode also covers approaches to managing complications, addressing treatment-related side effects, and delivering patient-centered care. Don’t miss this informative episode! Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL Recorded on May 28, 2026 Tara Gregory, MD President Colorado Blood Cancer Institute Denver, CO Jay Spiegel, MD Assistant Professor Division of Transplant and Cellular Therapy University of Miami Sylvester Comprehensive Cancer Center Miami, FL In this episode, Dr. Tara Gregory from the Colorado Blood Cancer Institute, and Dr. Jay Spiegel from the Sylvester Comprehensive Cancer Center discuss the evolving role of CAR T-cell therapy in lymphoma and myeloma. They provide a practical overview of CAR-T, including currently approved indications, importance of early referral, patient selection considerations, and strategies for engaging patients in treatment discussions. The conversation also covers key aspects of toxicity management and post-treatment monitoring, while addressing current limitations of CAR-T therapy and future directions that may further expand its role in patient care. Tune in today for this exciting episode! Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients This episode is supported by Bristol Myers Squibb, Johnson & Johnson & Legend Biotech, and Kite, a Gilead Company.

Lori Muffly, MD, MS, Stanford Medicine, Stanford, CA Recorded on May 12, 2026 Lori Muffly, MD, MS Professor of Medicine Division of Blood and Marrow Transplantation & Cellular Therapy Stanford Medicine Stanford, CA In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams, and resources to support patients and healthcare professionals. Join us for this insightful episode on the important role of HSCT today, and where it’s headed next. Mentioned on this episode: www.NMDP.org www.hematology.org Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

Mayra Allen, PhD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Recorded on April 23, 2026 Mayra Allen, PhD Clinical Psychologist, Psycho-Oncology Service UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, CA Join us for an insightful conversation with Mayra Allen, PhD, clinical psychologist at UCSF’s Helen Diller Family Comprehensive Cancer Center, as we explore actionable strategies for supporting couples, caregivers, and families navigating cancer care. This episode examines practical communication approaches, the evolving role of care partners, and ways to help families manage complex situations. The discussion also addresses important yet often overlooked topics, including changes in intimacy, the impact of cultural perspectives across the cancer journey, and resources to support clinicians in delivering whole person oncology care. Tune in to this thoughtful discussion today! Mentioned on this episode: Caregivers Action Network (CAN) Family Caregiver Alliance Women’s Cancer Resource Center Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

David Sallman, MD, Moffitt Cancer Center, Tampa, FL Recorded on April 9, 2026 David Sallman, MD Associate Member, Department of Malignant Hematology Moffitt Cancer Center Tampa, FL In this exciting episode, Dr. David Sallman from Moffitt Cancer Center takes a deep dive into acute myeloid leukemia (AML) and the advances transforming patient care. The discussion spans newly approved therapies, including menin inhibitors, as well as promising approaches under investigation in clinical trials, and explores how these innovations are influencing treatment selection, transplantation, and the management of side effects and complications in today’s AML landscape. Tune in today for expert insight into what’s shaping the future of AML care. Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients This episode is supported by Kura Oncology, Inc.

Matthew Loscalzo, LCSW, APOS Fellow, City of Hope, Duarte, CA Recorded on March 30, 2026 Matthew Loscalzo, LCSW, APOS Fellow Founding Executive Director and Professor Emeritus of Supportive Care Medicine and Professor of Population Sciences City of Hope Duarte, CA In this episode, licensed clinical social worker Matthew Loscalzo explores how survivors and healthcare professionals often define “normal” differently after treatment. He discusses the emotional shifts that impact relationships, work, and future planning, and shares how healthcare professionals can support meaningful conversations and shared decision-making after treatment ends. Tune in to hear practical insights for supporting patients beyond treatment. Mentioned on this episode: Loss and Grief: Personal Stories of Doctors and Other Healthcare Professionals by Linda Klein, Matthew Loscalzo (Editor), Marshall Forstein (Editor) Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

Amy Pierre, MSN, ANP-BC, Flatiron Health and Memorial Sloan Kettering, New York, NY and Peter Voorhees, MD, Levine Cancer Institute, Charlotte, NC Recorded on March 10, 2026 Amy Pierre, MSN, ANP-BC Senior Clinical Director, Research Oncology, Flatiron Health Nurse Practitioner, Memorial Sloan Kettering Cancer Center New York, NY Peter Voorhees, MD Director, Outreach for Hematologic Malignancies, Plasma Cells Disorder Program, Department of Hematologic Oncology and Blood Disorders Levine Cancer Institute Charlotte, NC Professor, Cancer Medicine Wake Forest University School of Medicine Winston-Salem, NC In this episode, Dr. Peter Voorhees from the Levine Cancer Institute and Amy Pierre, MSN, RN, ANP BC from Flatiron Health and Memorial Sloan Kettering, break down the evolving landscape of myeloma, from early signs and diagnostic criteria to frontline therapy, transplant decisions, and T- cell redirecting therapies. They explore real world challenges in survivorship, treatment toxicity, and disparities in access to advanced therapies, offering practical insights to help care teams support patients more effectively. Tune in for an informative and forward looking discussion shaping the future of myeloma management. Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

Matthew Kutny, MD, University of Alabama, Birmingham, AL, Julie Guillot, Pediatric AML parent, global advocate, and Blood Cancer United Volunteer, and Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC Recorded on February 19, 2026 Matthew Kutny, MD Professor of Pediatrics Director, Leukemia, Lymphoma and Histiocytosis Program Director, Pediatric Clinical Trials Office Institutional Principal Investigator, Children’s Oncology Group (NCI NCTN) Pediatric Hematology and Oncology University of Alabama at Birmingham Birmingham, AL Julie Guillot Pediatric AML parent, global advocate, and Blood Cancer United Volunteer Kelly Laschinger, MSN, RN, CPNP, CPHON Director, Clinical Trial Support Center Blood Cancer United Washington, DC In this episode, Dr. Matthew Kutny from the University of Alabama, and Kelly Laschinger, CPNP and Julie Guillot from Blood Cancer United, break down what clinicians and families need to know about Expanded Access (EA), also known as Compassionate Use, in treating pediatric oncology patients. They clarify key terms, outline when EA should be considered, and walk through how the process works in real-world practice. Their conversation also addresses common barriers, from institutional requirements to sponsor approval, and highlights how pediatric care teams and advocates can work together to navigate them. Tune in for an informative and insightful conversation to help healthcare professionals better understand and utilize Expanded Access! Blood Cancer United Resources: Clinical Trial Support Center Information Resource Center Dare to Dream Project Pediatric Acute Leukemia Master Clinical Trial (PedAL) Mentioned on this episode: Project Facilitate This episode is supported by the Tom Reich Educational Endowment Fund.